In recent years, many studies have proposed that FABP4 could serve as a valid biomarker for obesity, and early detection of diabetic nephropathy, T2DM, and GDM [19,21,22]. This evidence concerns the gene FABP4 and obesity due to melanocortin 4 receptor deficiency.